1:22
Kathy Oubre, MS, comments on the recent criticism regarding the use of biosimilars
197 views • 3 years ago
2:35
Kathy Oubre, MS, offers opinion on whether biosimilars are living up to their estimated cost savings
95 views • 3 years ago
2:36
Kathy Oubre, MS, speculates on the future of biosimilars
153 views • 3 years ago
2:00
Kathy Oubre, MS, considers how comfortable physicians and payers are with biosimilars
137 views • 3 years ago
3:16
Bo Gamble, on the most important critical success factors when adopting a new payment model
43 views • 3 years ago
3:07
Alti Rahman, MHA\MBA, CSSBB, reflects on social determinants of health in cancer care
130 views • 3 years ago
3:52
Bo Gamble, discusses the impact of consolidation on the delivery of cancer care
46 views • 3 years ago
3:05
Bo Gamble, speculates on the future of alternative payment models (APMs)
77 views • 3 years ago
3:02
Alti Rahman, MHA\MBA, CSSBB, offers advice to oncology practices in today's cancer care landscape
227 views • 3 years ago
2:39
Alti Rahman, MHA\MBA, CSSBB, regarding the impact of consolidation on the delivery of cancer care
48 views • 3 years ago
3:17
Bo Gamble, considers how value & quality may vary across community oncology practices
29 views • 3 years ago
1:59
Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care
50 views • 3 years ago
2:13
Alti Rahman, MHA\MBA, CSSBB, considers how oncology practices can reduce costs & maximize savings
116 views • 3 years ago
2:36
Alti Rahman, MHA\MBA, CSSBB, provides perspective on the challenges facing oncology practices
65 views • 3 years ago
2:19
Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists
198 views • 3 years ago
3:04
Johnetta Blakely, MD, offers an example of how HEOR has impacted cancer care at Tennessee Oncology
284 views • 3 years ago
1:47
Johnetta Blakely, MD, elaborates on how HEOR may be used in conjunction with real-world evidence
68 views • 3 years ago
1:32
Johnetta Blakely, MD, considers how HEOR data influences payer decisions
205 views • 3 years ago
2:13
Johnetta Blakely, MD, explains the role of HEOR as it contributes to value-based care
417 views • 3 years ago
1:08
Jonathan E. Levitt, Esq., on the experience of hem/onc groups unable to enter into a PBM network
79 views • 3 years ago
3:31
Jonathan E. Levitt, Esq., explains how copay aggregators differ across PBMs
20 views • 3 years ago
3:44
Jonathan E. Levitt, Esq., offers opinion on PBM consolidation & the changing dynamics of cancer care
19 views • 3 years ago
1:47
Jonathan E. Levitt, Esq., considers how PBM behaviors are changing as a result of the pandemic
13 views • 3 years ago
2:42
Jonathan E. Levitt, Esq., explains how DIR fees impact practice costs and efficiencies
121 views • 3 years ago
3:31
Jonathan E. Levitt, Esq., discusses the state of payer mandates for white / brown bagging
45 views • 3 years ago
1:57
Sara Riordan, MS, CGC, on the role of genetic counselors as part of a multidisciplinary cancer team
178 views • 3 years ago
1:52
Sara Riordan, MS, CGC, regarding the significance of biomarker testing in early-stage cancer
104 views • 3 years ago
2:36
Sara Riordan, MS, CGC, on how genetic signature & biomarker tests are used in cancer management
65 views • 3 years ago
2:02
Sara Riordan, MS, CGC, elaborates on the unmet needs in biomarker testing
67 views • 3 years ago
1:03
Lalan S. Wilfong, MD, discusses key takeaways from the 2021 Virtual Community Oncology Conference
20 views • 3 years ago
Load More